Rationale for Randomized Clinical Trials Investigating the Potential of BCG Vaccination in...Read More
Bladder Cancer Journal
Posted by Bladder Cancer Journal | Dec 2020
Upregulated FGFR3 signaling in NMIBC and MIBC, the diagnosis and management of checkpoint inhibitor side effects in bladder cancer patients, the etiology of treatment delays in patients receiving neoadjuvant chemotherapy for MIBC, and 25-year trends in stage-specific incidence rates for bladder cancer.Read More
Join the GRU Community- Why Join? -
CARDEN JENNINGS PUBLISHING CO., LTD.
- PDF Embedder Test Jan 2022
- Genetic Testing and Prostate Cancer – Welcome Jan 2022
- Current Status of PSMA Diagnostics Aug 2021
- Genetic Testing and Prostate Cancer Aug 2021
- What’s New in Active Surveillance for Prostate Cancer in 2021 Aug 2021
Exercise & Wellness
Fred Bartlit, Esq.
Mark A. Moyad, MD, MPH
University of Michigan
Ann Arbor, Michigan